Butylscopolamine - Hioscine Butylbromide

Butylscopolamine - Hioscine Butylbromide

Pharmaceutical Products, OTC
Butylscopolamine - Hioscine Butylbromide
Butylscopolamine - Hioscine Butylbromide

Information

Peripherally-acting anticholinergic agent known for its antispasmodic properties. We have been producing our Butylscopolamine since 1985, sourcing it from the leaves of the Duboisia plant. As from 2022, this raw material is processed at our own facility in Australia. Linnea is the official supplier to EDQM for Ph.Eur. Analytical Standard for Hyoscine butylbromide for system suitability CRS. General grade butylscopolamine is suitable for diverse pharmaceutical forms. Hyject butylscopolamine is suitable for injectable pharmaceutical forms. Common pharmaceutical uses include smooth-muscle relaxation, renal colic pain, dysmenorrhoea and irritable bowel syndrome. CEP & DMF available - Ph.Eur. compliant - GACP compliant - manufactured under GMP standards
Linnea SAS11.D94Linnea is a leading Swiss-based company specialized in the manufacturing of premium botanical active ingredients for the pharmaceutical, natural food and cosmetic industries. Committed to sustainability and innovation, Linnea ensures that all products meet the highest standards of quality and regulatory compliance. Since its foundation in 1982, Linnea has been at the forefront of botanical ingredient manufacturing, distinguished by its expertise, quality, and dedication to excellence. Operating from our GMP-certified facility and in alignment with GACP guidelines, we ensure exceptional, validated product quality. Our stringent controls and standardized production processes deliver consistent, reliable batch-to-batch performance at all times. We also stand out as a leader in the emerging medical cannabinoids sector, applying a pharma-driven approach to the development of cannabinoid-based therapies. Serving over 300 clients in more than 50 countries, we provide our partners with tailored regulatory, scientific and commercial support. In-house research, extensive academic collaborations, and a strong commitment to scientific advancement drive our approach to continuous excellence.

Log in

See all the content and easy-to-use features by logging in or registering!